Connect your AI

Amphastar Pharmaceuticals AMPH Net margin

Net margin at other companies

PfizerPFE

15.7%—

Halozyme TherapeuticsHALO

47.9%+6.5pp

ViatrisVTRS

-2%-1.0pp

Opko HealthOPK

-36.6%-44.8pp

AptarGroupATR

10%-0.4pp

ARS Pharmaceuticals, Inc.SPRY

-200%-219pp

Other financials

Income statement

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.4%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

FCF margin18.8%-1.8pp

Returns & leverage

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

net income/total revenue=11%

Based on trailing twelve months.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Amphastar Pharmaceuticals's net margin?: Amphastar Pharmaceuticals (AMPH) reported net margin of 11% in Q1 2026.
How has Amphastar Pharmaceuticals's net margin changed year-over-year?: Amphastar Pharmaceuticals's net margin decreased by 43.3% year-over-year, from 19.4% to 11%.
What is the long-term trend for Amphastar Pharmaceuticals's net margin?: Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's net margin has grown at a -1.0% compound annual growth rate (CAGR), from 14.2% to 13.6%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.